Intense 18F-PSMA-1007 Uptake of Splenic Hemangioma

被引：1
|
作者：
Jia, Guorong [1 ]
Dong, Aisheng [1 ]
Cheng, Chao [1 ]
Zuo, Changjing [1 ]
机构：
[1] Naval Med Univ, Dept Nucl Med, Affiliated Hosp 1, 168 Changhai Rd, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 02期
关键词：
spleen; hemangioma; PSMA; PET/CT; MEMBRANE ANTIGEN PET/CT;
D O I：
10.1097/RLU.0000000000004995
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 77-year-old man was referred for F-18-PSMA-1007 PET/CT scan for initial staging of biopsy-proved prostate adenocarcinoma. F-18-PSMA-1007 PET/CT showed focal intense F-18-PSMA-1007 of the prostate adenocarcinoma and a focal intense activity (SUVmax, 27) in the spleen. The F-18-PSMA-1007-avid splenic lesion corresponded to a splenic hemangioma, which was initially detected on contrast-enhanced CT 7 months ago and unchanged in size and enhancement pattern on follow-up contrast-enhanced CT. This case indicates that splenic hemangioma should be included in the differential diagnosis of PSMA-avid splenic lesions.
引用
收藏
页码：e90 / e92
页数：3
相关论文
共 50 条
  • [21] Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007
    Seifert, Robert
    Schafigh, Darius
    Boegemann, Martin
    Weckesser, Matthias
    Rahbar, Kambiz
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E394 - E395
  • [22] Comparison of the 18F-PSMA-1007 and 18F-FAPI-42 PET/ CT in the evaluation of prostate cancer and correlation between PSMA and FAPI uptake
    Mu, X.
    Li, M.
    Fu, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S536 - S536
  • [23] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Hu, Yuan
    Wang, Peng
    Dai, Wenli
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [24] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Yuan Hu
    Peng Wang
    Wenli Dai
    BMC Pulmonary Medicine, 23
  • [25] 18F-PSMA-1007: The Optimal Variant of Radiofluorinated PSMA Ligands Derived from PSMA-617
    Cardinale, J.
    Schaefer, M.
    Geerlings, M.
    Benesova, M.
    Eder, M.
    Bauder-Wuest, U.
    Baranski, A.
    Neels, O.
    Leotta, K.
    Haberkorn, U.
    Giesel, F.
    Kopka, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S14 - S14
  • [26] Assessment of benign bone marrow uptake with 18F-PSMA-1007 in prostate cancer using PET/MRI
    Afaq, Asim
    Wan, Ming Young Simon
    Priftakis, Dimitrios
    Kayani, Irfan
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [27] Osteonecrosis of the Femoral Head as a Potential Pitfall in 18F-PSMA-1007 PET
    Bailly, Matthieu
    Ibrahim, Nada
    Champeaux-Orange, Elise
    Metrard, Gilles
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 74 - 75
  • [28] 18F-PSMA-1007 Synthesis: a production upgrade that enabled a federal experience in Argentina
    Agolti, M.
    Messina, G.
    Casale, G.
    Solari, L.
    Sandobal, J.
    Fila, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S411 - S411
  • [29] Initial Results with 18F-PSMA-1007 in Prostate Cancer Patients with Biochemical Recurrence
    Giesel, F. L.
    Will, L.
    Cardinale, J.
    Neels, O. C.
    Radtke, J. P.
    Kopka, K.
    Haberkorn, U.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S369 - S369
  • [30] Comparison of Internal Dosimetry of 18F-PSMA-1007 and 68Ga-PSMA-11-HBED-CC
    Sharma, Priya
    Watts, Ankit
    Singh, Harmandeep
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : 948 - 953
12345